Vanguard Group Inc Acumen Pharmaceuticals, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ABOS
# of Institutions
77Shares Held
41.7MCall Options Held
57.7KPut Options Held
70.6K-
Ra Capital Management, L.P. Boston, MA14.9MShares$37.8 Million0.52% of portfolio
-
Franklin Resources Inc San Mateo, CA3.55MShares$8.98 Million0.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$8.65 Million4.37% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$5.82 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$5.46 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $102M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...